IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INAB IN8bio, Inc.

已收盘 11-22 16:00:00 EST

0.3176

-0.0024

-0.75%

盘后0.3282

+0.0106+3.34%

19:55 EST

最高0.3270	最低0.3107	成交量17.03万
今开0.3200	昨收0.3200	日振幅5.09%
总市值2,302万	流通市值1,733万	总股本7,248万
成交额5.44万	换手率0.31%	流通股本5,457万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":0.3176,"timestamp":1732309200000,"preClose":0.32,"halted":0,"volume":170253,"hourTrading":{"tag":"盘后","latestPrice":0.3282,"preClose":0.3176,"latestTime":"19:55 EST","volume":2924,"amount":940.4295,"timestamp":1732323346922},"delay":0,"floatShares":54568000,"shares":72483253,"eps":-0.742548,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.0024,"latestTime":"11-22 16:00:00 EST","open":0.32,"high":0.327,"low":0.3107,"amount":54413.83605222,"amplitude":0.050938,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.742548,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1605157200000,"adjPreClose":0.32,"preHourTrading":{"tag":"盘前","latestPrice":0.32,"preClose":0.32,"latestTime":"09:08 EST","volume":839,"amount":267.8854007,"timestamp":1732284535814},"postHourTrading":{"tag":"盘后","latestPrice":0.3282,"preClose":0.3176,"latestTime":"19:55 EST","volume":2924,"amount":940.4295,"timestamp":1732323346922},"volumeRatio":0.470198},"requestUrl":"/m/hq/s/INAB/tweets","defaultTab":"tweets","newsList":[{"id":"2485441864","title":"In8Bio, Inc.盘中异动 股价大涨8.62%报0.349美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485441864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485441864?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:45","pubTimestamp":1732200322,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时45分，In8Bio, Inc.股票出现异动，股价大幅上涨8.62%。截至发稿，该股报0.349美元/股，成交量1.8285万股，换手率0.03%，振幅2.27%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224522abd4ecf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224522abd4ecf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2485014999","title":"In8Bio, Inc.2024财年第三财季实现净利润-7.09百万美元，同比增加1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485014999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485014999?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:00","pubTimestamp":1732118437,"startTime":"0","endTime":"0","summary":"11月21日，In8Bio, Inc.公布财报，公告显示公司2024财年第三财季净利润为-7.09百万美元，同比增加1.12%；其中营业收入为0.00美元，每股基本收益为-0.15美元。从资产负债表来看，In8Bio, Inc.总负债7.38百万美元，其中短期债务1.73百万美元，资产负债比为2.17，流动比率为1.85。机构评级：截至2024年11月21日，当前有5家机构对In8Bio, Inc.目标价做出预测，其中目标均价为4.10美元，其中最低目标价为1.50美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000044abd25bd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000044abd25bd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB"],"gpt_icon":0},{"id":"2484972491","title":"In8Bio, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484972491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484972491?lang=zh_cn&edition=full","pubTime":"2024-11-20 03:29","pubTimestamp":1732044586,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日03时29分，In8Bio, Inc.股票出现波动，股价急速下挫5.16%。截至发稿，该股报0.315美元/股，成交量21.9672万股，换手率0.30%，振幅5.01%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.43%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120032946971a781a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120032946971a781a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2483301844","title":"In8Bio, Inc.盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483301844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483301844?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:13","pubTimestamp":1731687204,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日00时13分，In8Bio, Inc.股票出现波动，股价大幅下跌5.24%。截至发稿，该股报0.318美元/股，成交量25.0355万股，换手率0.35%，振幅9.40%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为3.95%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116001324971a6e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116001324971a6e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2483135336","title":"In8Bio, Inc.盘中异动 下午盘股价大涨9.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483135336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483135336?lang=zh_cn&edition=full","pubTime":"2024-11-15 03:31","pubTimestamp":1731612670,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日03时31分，In8Bio, Inc.股票出现波动，股价大幅拉升9.73%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115033111abc1f22e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115033111abc1f22e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2483703667","title":"In8Bio, Inc.盘中异动 临近午盘急速拉升5.42%报0.350美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483703667","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483703667?lang=zh_cn&edition=full","pubTime":"2024-11-13 00:55","pubTimestamp":1731430514,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日00时55分，In8Bio, Inc.股票出现波动，股价快速上涨5.42%。截至发稿，该股报0.350美元/股，成交量9.9429万股，换手率0.14%，振幅4.58%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113005515a2310bbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113005515a2310bbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2482381357","title":"In8Bio, Inc.盘中异动 早盘股价大跌6.37%报0.322美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482381357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482381357?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:44","pubTimestamp":1731336277,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时44分，In8Bio, Inc.股票出现波动，股价大幅下挫6.37%。截至发稿，该股报0.322美元/股，成交量5.9313万股，换手率0.08%，振幅6.69%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224437971a5b6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224437971a5b6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2482437970","title":"In8Bio, Inc.盘中异动 股价大涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482437970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482437970?lang=zh_cn&edition=full","pubTime":"2024-11-09 03:52","pubTimestamp":1731095537,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日03时52分，In8Bio, Inc.股票出现波动，股价快速上涨5.78%。截至发稿，该股报0.350美元/股，成交量24.3598万股，换手率0.34%，振幅7.26%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.25%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109035218abaed868&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109035218abaed868&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2481138769","title":"In8Bio, Inc.盘中异动 大幅下跌5.90%报0.314美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481138769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481138769?lang=zh_cn&edition=full","pubTime":"2024-11-08 00:21","pubTimestamp":1730996475,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日00时21分，In8Bio, Inc.股票出现波动，股价快速跳水5.90%。截至发稿，该股报0.314美元/股，成交量27.483万股，换手率0.38%，振幅4.53%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110800211698e41402&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110800211698e41402&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2481313985","title":"In8Bio, Inc.盘中异动 早盘大幅下挫9.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481313985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481313985?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:33","pubTimestamp":1730903633,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时33分，In8Bio, Inc.股票出现波动，股价快速跳水9.05%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223353971a4c2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223353971a4c2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2481670685","title":"In8Bio, Inc.盘中异动 早盘股价大涨6.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481670685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481670685?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:59","pubTimestamp":1730818794,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时59分，In8Bio, Inc.股票出现异动，股价急速上涨6.96%。截至发稿，该股报0.326美元/股，成交量14.0476万股，换手率0.19%，振幅6.50%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105225954a218d337&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105225954a218d337&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2480370581","title":"In8Bio, Inc.盘中异动 股价大涨5.80%报0.303美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480370581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480370581?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:41","pubTimestamp":1730731264,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时41分，In8Bio, Inc.股票出现异动，股价大幅上涨5.80%。截至发稿，该股报0.303美元/股，成交量10.3732万股，换手率0.14%，振幅8.03%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104224104ab9ec2a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104224104ab9ec2a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2480052386","title":"In8Bio, Inc.盘中异动 下午盘大幅上涨6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480052386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480052386?lang=zh_cn&edition=full","pubTime":"2024-11-01 02:00","pubTimestamp":1730397646,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日02时00分，In8Bio, Inc.股票出现波动，股价大幅拉升6.37%。截至发稿，该股报0.287美元/股，成交量14.5046万股，换手率0.20%，振幅9.33%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为3.61%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101020046a2034c94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101020046a2034c94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2479728805","title":"In8Bio, Inc.盘中异动 股价大跌6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479728805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479728805?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:35","pubTimestamp":1730208926,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时35分，In8Bio, Inc.股票出现波动，股价快速跳水6.45%。截至发稿，该股报0.282美元/股，成交量4.8903万股，换手率0.07%，振幅2.56%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213526971a2ec6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213526971a2ec6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2479943660","title":"In8Bio, Inc.盘中异动 股价大跌5.06%报0.294美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479943660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479943660?lang=zh_cn&edition=full","pubTime":"2024-10-28 23:58","pubTimestamp":1730131114,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日23时58分，In8Bio, Inc.股票出现波动，股价大幅下跌5.06%。截至发稿，该股报0.294美元/股，成交量15.8665万股，换手率0.22%，振幅6.42%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823583498e3ee09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823583498e3ee09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2478935704","title":"In8Bio, Inc.盘中异动 大幅跳水6.09%报0.301美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478935704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478935704?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:58","pubTimestamp":1729864708,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时58分，In8Bio, Inc.股票出现波动，股价快速下跌6.09%。截至发稿，该股报0.301美元/股，成交量5.3222万股，换手率0.07%，振幅9.75%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025215829971a2560&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025215829971a2560&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2477313096","title":"In8Bio, Inc.盘中异动 早盘股价大跌7.04%报0.301美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477313096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477313096?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:34","pubTimestamp":1729776890,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时34分，In8Bio, Inc.股票出现波动，股价急速跳水7.04%。截至发稿，该股报0.301美元/股，成交量5.555万股，换手率0.08%，振幅4.66%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024213450971a20e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024213450971a20e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2477153821","title":"In8Bio, Inc.盘中异动 股价大跌6.55%报0.307美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477153821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477153821?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:34","pubTimestamp":1729690441,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时34分，In8Bio, Inc.股票出现波动，股价快速跳水6.55%。截至发稿，该股报0.307美元/股，成交量32.6097万股，换手率0.45%，振幅2.77%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321340195bd4301&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321340195bd4301&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2477337870","title":"In8Bio, Inc.盘中异动 早盘快速跳水17.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477337870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477337870?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:31","pubTimestamp":1729603894,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时31分，In8Bio, Inc.股票出现波动，股价快速下挫17.79%。截至发稿，该股报0.391美元/股，成交量72.9684万股，换手率1.01%，振幅5.03%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221313595bb6c31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221313595bb6c31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2477866992","title":"In8Bio, Inc.盘中异动 股价大涨6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477866992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477866992?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:35","pubTimestamp":1729517704,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时35分，In8Bio, Inc.股票出现异动，股价急速上涨6.64%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410212135049f53fa2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410212135049f53fa2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.in8bio.com","stockEarnings":[{"period":"1week","weight":-0.0476},{"period":"1month","weight":-0.0244},{"period":"3month","weight":-0.4019},{"period":"6month","weight":-0.6832},{"period":"1year","weight":-0.5616},{"period":"ytd","weight":-0.7681}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"In8bio, Inc.于2016年2月8日在百慕大注册成立。2018年5月7日，该公司在一项交易中重新并入美国，在该交易中，该公司转变为一家新成立的特拉华州公司，该公司是一家临床阶段生物技术公司，专注于通过使用同种异体、自体和基因修饰的γ-δT细胞。γ-δT细胞是人体免疫系统中自然产生的细胞，它识别并杀死癌细胞，同时具有保护健康组织的肿瘤识别机制。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.098793},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.077829},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.098136},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.097265},{"month":5,"riseRate":0.666667,"avgChangeRate":0.389911},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.253166},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.039223},{"month":8,"riseRate":0.25,"avgChangeRate":-0.195936},{"month":9,"riseRate":0.25,"avgChangeRate":-0.177333},{"month":10,"riseRate":0.5,"avgChangeRate":0.013341},{"month":11,"riseRate":0.25,"avgChangeRate":-0.086639},{"month":12,"riseRate":0.666667,"avgChangeRate":0.246461}],"exchange":"NASDAQ","name":"IN8bio, Inc.","nameEN":"IN8bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"IN8bio, Inc.,INAB,IN8bio, Inc.股票,IN8bio, Inc.股票老虎,IN8bio, Inc.股票老虎国际,IN8bio, Inc.行情,IN8bio, Inc.股票行情,IN8bio, Inc.股价,IN8bio, Inc.股市,IN8bio, Inc.股票价格,IN8bio, Inc.股票交易,IN8bio, Inc.股票购买,IN8bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}